Related Experiment Video
Updated: Oct 10, 2025
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.9K
Analysis of somatic copy number alterations in biliary tract carcinoma using a single nucleotide polymorphism array
Yoshihiro Shioi1,2, Mitsumasa Osakabe1, Naoki Yanagawa1
1Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, 2-1-1, Shiwagun, Yahabachou, 0283695, Japan.
Future Science OA
|December 13, 2021
Summary
Gallbladder and biliary duct carcinomas show distinct genetic profiles. Somatic copy number alterations (SCNAs) analysis revealed differences, aiding understanding of biliary tract carcinoma (BTC) molecular origins.
Area of Science:
- Genomic analysis of biliary tract carcinoma (BTC).
- Investigating the molecular basis of gallbladder carcinoma (GBC) and biliary duct carcinoma (BDC).
Background:
- Biliary tract carcinoma (BTC), encompassing GBC and BDC, is associated with poor patient outcomes.
- Comprehensive genomic profiling is crucial for understanding BTC development.
Purpose of the Study:
- To analyze somatic copy number alterations (SCNAs) in BTC.
- To differentiate the genetic landscapes of GBC and BDC.
- To contribute to understanding the molecular carcinogenesis of BTC.
Main Methods:
- Somatic copy number alterations (SCNAs) were assessed using a single nucleotide polymorphism (SNP) array.
- Analysis was performed on 36 BTC samples, including 11 GBCs and 25 BDCs.
Main Results:
- Hierarchical clustering identified two distinct subgroups based on SCNA levels: low (subgroup 1) and high (subgroup 2).
- Gallbladder carcinoma (GBC) was predominantly found in subgroup 1 (low SCNAs).
- Biliary duct carcinoma (BDC) was predominantly found in subgroup 2 (high SCNAs), indicating different genetic underpinnings.
Conclusions:
- The study highlights distinct SCNA profiles between GBC and BDC.
- These findings provide insights into the differential molecular carcinogenesis of BTC subtypes.
- Results may inform future strategies for BTC evaluation and treatment.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
18.1K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.1K
02:21Cancers Originate from Somatic Mutations in a Single Cell
13.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
01:05Single Nucleotide Polymorphisms-SNPs
16.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.8K